Impact of the updating of clinical guidelines for RSV bronchiolitis on the use of diagnostic testing and medications in tertiary hospitals in Colombia

Impact of the updating of clinical guidelines for RSV bronchiolitis on the use of diagnostic testing and medications in tertiary hospitals in Colombia

<p><strong>Introduction:</strong> the incidence of Respiratory Syncytial Virus (RSV) infection and their variability in the clinical management, make this disease a candidate for monitoring adequate use of resources. The objective of this study was to evaluate the impact of the upd...

Descripció completa

Dades bibliogràfiques
Autors principals:	Buendia Rodriguez, JA, Patino, DG
Format:	Journal article
Idioma:	English
Publicat:	African Field Epidemiology Network 2022

Ítems similars

Disability-adjusted life years for acute bronchiolitis in infants in Colombia
per: Buendía, JA, et al.
Publicat: (2021)

TLR4 gene polymorphisms interaction with Ascaris infection in severe RSV bronchiolitis
per: Buendia Rodriguez, JA, et al.
Publicat: (2022)

Budget impact analysis of hypertonic saline inhalations for infant bronchiolitis: the Colombian national health system perspective
per: Buendía. JA, et al.
Publicat: (2021)

Clinical severity of RSV bronchiolitis
per: Faris Hussain, et al.
Publicat: (2022-03-01)

Nasal Microbiota in RSV Bronchiolitis
per: Serena Schippa, et al.
Publicat: (2020-05-01)

A predictive model of inappropriate use of medical tests and medications in bronchiolitis
per: Buendía, JA, et al.
Publicat: (2020)

The Differences Between RSV and no RSV Acute Bronchiolitis in Hospitalized Infants: A Cross-Sectional Study
per: Evangelos Christou, et al.
Publicat: (2022-12-01)

The Contribution of Neutrophils to the Pathogenesis of RSV Bronchiolitis
per: Ismail Sebina, et al.
Publicat: (2020-07-01)

The Use of Albuterol in Young Infants Hospitalized with Acute RSV Bronchiolitis
per: Michael T. Del Vecchio, et al.
Publicat: (2012-01-01)

TLR4 Gene Polymorphisms Interaction With Ascaris Infection in Severe RSV Bronchiolitis
per: Jefferson Antonio Buendía, et al.
Publicat: (2022-04-01)

HLA class I antigens in severe RSV bronchiolitis.
per: Isaacs, D, et al.
Publicat: (1989)

UPDATE - 2022 Italian guidelines on the management of bronchiolitis in infants
per: Sara Manti, et al.
Publicat: (2023-02-01)

Clinical, laboratory and radiological features of RSV-bronchiolitis in premature infants
per: D. Yu. Ovsyannikov, et al.
Publicat: (2019-12-01)

Nasal and Fecal Microbiota and Immunoprofiling of Infants With and Without RSV Bronchiolitis
per: Claudio Alba, et al.
Publicat: (2021-06-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
per: Selir M. Straliotto, et al.
Publicat: (1994-03-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
per: Selir M. Straliotto, et al.
Publicat: (1994-03-01)

Impact of RSV test positivity, patient characteristics, and treatment characteristics on the cost of hospitalization for acute bronchiolitis in a French university medical center (2010–2015)
per: Benoit Dervaux, et al.
Publicat: (2023-07-01)

Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study.
per: Joanna Murray, et al.
Publicat: (2014-01-01)

Computerized acoustic assessment of treatment efficacy of nebulized epinephrine and albuterol in RSV bronchiolitis
per: Talmon Gil, et al.
Publicat: (2007-06-01)

Demographic, Clinical and Hematological Profile of Children with Bronchiolitis: A Comparative Study between Respiratory Synctial Virus [RSV] and [Non RSV] Groups
per: Ganavi Ramagopal, et al.
Publicat: (2016-08-01)

Inappropriate antibiotic prescribing for acute bronchiolitis in Colombia: a predictive model
per: Jefferson Antonio Buendía, et al.
Publicat: (2021-12-01)

Clinical manifestations and outcomes of respiratory syncytial virus infection in children less than two years in Colombia
per: Buendía, JA, et al.
Publicat: (2020)

Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster.
per: Forton, J, et al.
Publicat: (2009)

A Polymorphism in the Catalase Gene Promoter Confers Protection against Severe RSV Bronchiolitis
per: Jeffrey M. Chambliss, et al.
Publicat: (2020-01-01)

The impact of the recent AAP changes in palivizumab authorization on RSV-induced bronchiolitis severity and incidence
per: Antonino Capizzi, et al.
Publicat: (2017-08-01)

Immunopathology of RSV: An Updated Review
per: Harrison C. Bergeron, et al.
Publicat: (2021-12-01)

The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
per: Buendía, JA, et al.
Publicat: (2020)

Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis [version 4; peer review: 2 approved]
per: Diana Guerrero Patino, et al.
Publicat: (2022-07-01)

Cost of illness of RSV infection in a middle-income tropical country
per: Jefferson Antonio Buendía, et al.
Publicat: (2021-08-01)

Respiratory Syncytial Virus (RSV) Update
per: Leonard R. Krilov, et al.
Publicat: (2022-09-01)

RSV infection of humanized lung-only mice induces pathological changes resembling severe bronchiolitis and bronchopneumonia
per: Chandrav De, et al.
Publicat: (2024-05-01)

Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre
per: Sara Manti, et al.
Publicat: (2022-11-01)

Relevance of RSV in hospitalized adults and the need for continued testing
per: Katherine Miller, et al.
Publicat: (2022-07-01)

Unnecessary antibiotic treatment of children hospitalised with respiratory syncytial virus (RSV) bronchiolitis: risk factors and prescription patterns
per: Uri Obolski, et al.
Publicat: (2021-12-01)

Pooled Sequencing of Candidate Genes Implicates Rare Variants in the Development of Asthma Following Severe RSV Bronchiolitis in Infancy.
per: Dara G Torgerson, et al.
Publicat: (2015-01-01)

Change in viral bronchiolitis management in hospitals in the UK after the publication of NICE guideline
per: Barr, R, et al.
Publicat: (2018)

Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma
per: Buendía, JA, et al.
Publicat: (2021)

Corticosteroids for the treatment of respiratory infection by Mycoplasma pneumoniae in children: a cost-utility analysis
per: Buendía, JA, et al.
Publicat: (2023)

Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma
per: Buendía, JA, et al.
Publicat: (2021)

Potential impact of nirsevimab and bivalent maternal vaccine against RSV bronchiolitis in infants: A population-based modelling study
per: Mónica López-Lacort, et al.
Publicat: (2024-08-01)